Home Liver Diseases Osr1 regulates hepatic inflammation and cell survival in the progression of non-alcoholic fatty liver disease

Osr1 regulates hepatic inflammation and cell survival in the progression of non-alcoholic fatty liver disease

Credits to the Source Link Daniel
Osr1 regulates hepatic inflammation and cell survival in the progression of non-alcoholic fatty liver disease
  • 1.

    Anstee QM, Targher G, Day CP. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol. 2013;10:330–44.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 2.

    Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2014;59:1174–97.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 3.

    Lim S, Oh TJ, Koh KK. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. Int J Cardiol. 2015;201:408–14.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 4.

    Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842–5.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 5.

    Liu W, Baker RD, Bhatia T, Zhu L, Baker SS. Pathogenesis of nonalcoholic steatohepatitis. Cell Mol Life Sci. 2016;73:1969–87.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 6.

    Machado MV, Diehl AM. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology. 2016;150:1769–77.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 7.

    Kodama Y, Brenner DA. c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: multiple roles in multiple steps. Hepatology. 2009;49:6–8.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 8.

    Tarantino G, Caputi A. JNKs, insulin resistance and inflammation: a possible link between NAFLD and coronary artery disease. World J Gastroenterol. 2011;17:3785–94.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 9.

    Malhi H, Bronk SF, Werneburg NW, Gores GJ. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem. 2006;281:12093–101.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 10.

    Czaja MJ. JNK regulation of hepatic manifestations of the metabolic syndrome. Trends Endocrinol Metab. 2010;21:707–13.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 11.

    Zeng L, Tang WJ, Yin JJ, Zhou BJ. Signal transductions and nonalcoholic fatty liver: a mini-review. Int J Clin Exp Med. 2014;7:1624–31.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • 12.

    Caron A, Richard D, Laplante M. The roles of mTOR complexes in lipid metabolism. Annu Rev Nutr. 2015;35:321–48.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 13.

    Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology. 2008;48:322–35.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 14.

    Miura K, Seki E, Ohnishi H, Brenner DA. Role of toll-like receptors and their downstream molecules in the development of nonalcoholic Fatty liver disease. Gastroenterol Res Pract. 2010;2010:362847.

    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 15.

    Kaidashev IP. NF-kB activation as a molecular basis of pathological process by metabolic syndrome. Fiziol Zh. 2012;58:93–101.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 16.

    Coulter DE, Swaykus EA, Beran-Koehn MA, Goldberg D, Wieschaus E, Schedl P. Molecular analysis of odd-skipped, a zinc finger encoding segmentation gene with a novel pair-rule expression pattern. Embo J. 1990;9:3795–804.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 17.

    Wang Q, Lan Y, Cho ES, Maltby KM, Jiang R. Odd-skipped related 1 (Odd 1) is an essential regulator of heart and urogenital development. Dev Biol. 2005;288:582–94.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 18.

    Xie L, Hoffmann AD, Burnicka-Turek O, Friedland-Little JM, Zhang K, Moskowitz IP. Tbx5-hedgehog molecular networks are essential in the second heart field for atrial septation. Dev Cell. 2012;23:280–91.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 19.

    Zhang KK, Xiang M, Zhou L, Liu J, Curry N, Heine Suner D, et al. Gene network and familial analyses uncover a gene network involving Tbx5/Osr1/Pcsk6 interaction in the second heart field for atrial septation. Hum Mol Genet. 2016;25:1140–51.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 20.

    Zhang Z, Iglesias D, Eliopoulos N, El Kares R, Chu L, Romagnani P, et al. A variant OSR1 allele which disturbs OSR1 mRNA expression in renal progenitor cells is associated with reduction of newborn kidney size and function. Hum Mol Genet. 2011;20:4167–74.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 21.

    Zhou L, Liu J, Olson P, Zhang K, Wynne J, Xie L. Tbx5 and Osr1 interact to regulate posterior second heart field cell cycle progression for cardiac septation. J Mol Cell Cardiol. 2015;85:1–12.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 22.

    Zhang Y, Yuan Y, Liang P, Guo X, Ying Y, Shu XS, et al. OSR1 is a novel epigenetic silenced tumor suppressor regulating invasion and proliferation in renal cell carcinoma. Oncotarget. 2017;8:30008–18.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 23.

    Zhao J, Liang Q, Cheung KF, Kang W, Lung RW, Tong JH, et al. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells. Cancer. 2013;119:304–12.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 24.

    Otani K, Dong Y, Li X, Lu J, Zhang N, Xu L, et al. Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer. J Pathol. 2014;234:302–15.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 25.

    Chen W, Wu K, Zhang H, Fu X, Yao F, Yang A. Corrigendum to “Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-kappaB pathway” [Eur. J. Pharmacol. 15 (2018) 33-39]. Eur J Pharmacol. 2019;847:158.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 26.

    Chen W, Wu K, Zhang H, Fu X, Yao F, Yang A. Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-kappaB pathway. Eur J Pharmacol. 2018;839:33–9.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 27.

    Du E, Lu C, Sheng F, Li C, Li H, Ding N, et al. Analysis of potential genes associated with primary cilia in bladder cancer. Cancer Manag Res. 2018;10:3047–56.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 28.

    Wang Y, Lei L, Zheng YW, Zhang L, Li ZH, Shen HY, et al. Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and beta-catenin. Cancer Sci. 2018;109:1799–810.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 29.

    Imajo K, Yoneda M, Kessoku T, Ogawa Y, Maeda S, Sumida Y, et al. Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Int J Mol Sci. 2013;14:21833–57.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • 30.

    Zhong F, Zhou X, Xu J, Gao L. Rodent models of nonalcoholic fatty liver disease. Digestion. 2020;101:522–35.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 31.

    Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther. 2017;34:1291–326.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 32.

    Krueger F, Andrews SR. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics. 2011;27:1571–2.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 33.

    Puri P, Sanyal AJ. Nonalcoholic fatty liver disease: definitions, risk factors, and workup. Clin Liver Dis. 2012;1:99–103.

    Article 

    Google Scholar
     

  • 34.

    Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci. 2009;116:539–64.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 35.

    Feng N, Luo J, Guo X. Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway. Mol Med Rep. 2016;13:3243–8.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 36.

    Fu YF, Liu X, Gao M, Zhang YN, Liu J. Endoplasmic reticulum stress induces autophagy and apoptosis while inhibiting proliferation and drug resistance in multiple myeloma through the PI3K/Akt/mTOR signaling pathway. Oncotarget. 2017;8:61093–106.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 37.

    Ramakrishnan V, Kumar S. PI3K/AKT/mTOR pathway in multiple myeloma: from basic biology to clinical promise. Leuk Lymphoma. 2018;59:2524–34.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 38.

    Tolba R, Kraus T, Liedtke C, Schwarz M, Weiskirchen R. Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice. Lab Anim. 2015;49:59–69.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • 39.

    Schneider C, Teufel A, Yevsa T, Staib F, Hohmeyer A, Walenda G, et al. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer. Gut. 2012;61:1733–43.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 40.

    Zhou Y, Xie L. High fat diet mouse model in the study of nonalcoholic fatty liver disease and hepatocellular carcinoma. Am J Digest Dis. 2015;2:6.


    Google Scholar
     

  • 41.

    Elsharkawy AM, Mann DA. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology. 2007;46:590–7.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 42.

    Luedde T, Schwabe RF. NF-kappaB in the liver–linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:108–18.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 43.

    Solinas G, Naugler W, Galimi F, Lee MS, Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc Natl Acad Sci USA. 2006;103:16454–9.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 44.

    Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, et al. A central role for JNK in obesity and insulin resistance. Nature. 2002;420:333–6.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 45.

    Kodama Y, Kisseleva T, Iwaisako K, Miura K, Taura K, De Minicis S, et al. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology. 2009;137:1467–77 e5.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 46.

    Solinas G, Vilcu C, Neels JG, Bandyopadhyay GK, Luo JL, Naugler W, et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 2007;6:386–97.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 47.

    Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, et al. Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology. 2008;135:1972–83. 83 e1-11

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 48.

    Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2002;3:221–7.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 49.

    Wullaert A, Heyninck K, Beyaert R. Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes. Biochem Pharmacol. 2006;72:1090–101.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • 50.

    Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 51.

    Daugaard I, Dominguez D, Kjeldsen TE, Kristensen LS, Hager H, Wojdacz TK, et al. Identification and validation of candidate epigenetic biomarkers in lung adenocarcinoma. Sci Rep. 2016;6:35807.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 52.

    Heinrichs D, Berres ML, Nellen A, Fischer P, Scholten D, Trautwein C, et al. The chemokine CCL3 promotes experimental liver fibrosis in mice. PLoS One. 2013;8:e66106.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • 53.

    Wang W, Yuasa T, Tsuchiya N, Ma Z, Maita S, Narita S, et al. The novel tumor-suppressor Mel-18 in prostate cancer: its functional polymorphism, expression and clinical significance. Int J Cancer. 2009;125:2836–43.

    CAS 
    PubMed 
    Article 
    PubMed Central 

    Google Scholar
     

  • Source Link

    Related Articles

    Leave a Comment

    This website uses cookies to improve your experience. We will assume you are ok with this, but you can opt-out if you wish. Accept Read More

    %d bloggers like this: